![Korro Bio Inc](/common/images/company/N_KRRO.png)
Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by degenerative diseases. Its Progenitor Cell Activation approach uses combinations of molecules to activate progenitor cells within the body to cre... Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by degenerative diseases. Its Progenitor Cell Activation approach uses combinations of molecules to activate progenitor cells within the body to create functional tissue. Its product candidate FX-322 is being developed for treating sensorineural hearing loss. Show more
CAMBRIDGE, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA...
CAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that members of management will participate in the following upcoming investor and...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.31 | -2.79436860068 | 46.88 | 53.6336 | 43.35 | 52595 | 49.69650646 | CS |
4 | 9.98 | 28.0415847148 | 35.59 | 53.6336 | 30.005 | 85081 | 38.26282608 | CS |
12 | -12.87 | -22.022587269 | 58.44 | 63.3 | 30.005 | 57942 | 43.13336658 | CS |
26 | 4.72 | 11.5544675643 | 40.85 | 97.91 | 30.005 | 43243 | 51.90797907 | CS |
52 | 32.57 | 250.538461538 | 13 | 97.91 | 13 | 48959 | 49.60821779 | CS |
156 | 32.57 | 250.538461538 | 13 | 97.91 | 13 | 48959 | 49.60821779 | CS |
260 | 32.57 | 250.538461538 | 13 | 97.91 | 13 | 48959 | 49.60821779 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.